Enhancing Anti-Allergic Transdermal Patches Through Box-Behnken Design Approach with Chlorpheniramine Maleate

Pharmaceutical sciences- Pharmaceutics

Authors

  • Hindustan Abdul Ahad Department of Pharmaceutics, RR College of Pharmacy, chikkabanawaraPharmacy, Chikkabanavara, Banglore-560001560090, Karnataka, India.
  • Siriguppa Dheeraj Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)-Autonomous, Ananthapuramu-515001, AP, India https://orcid.org/0000-0001-5321-9194
  • Haranath Chinthaginjala Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)-Autonomous, Ananthapuramu-515001, AP, India

DOI:

https://doi.org/10.22376/ijlpr.2023.13.6.P366-P377

Keywords:

Chlorpheniramine maleate, Design, In vitro studies, Permeation studies, Transdermal patch.

Abstract

This research focuses on developing transdermal patches incorporating chlorpheniramine maleate (CPM), an anti-allergic medication. Transdermal patches offer a convenient and effective way to administer drugs, and CPM's application in this context holds promise for improved patient care. The primary aim of this study was to utilize the Box-Behnken design to formulate transdermal patches containing CPM. These patches were developed through a solvent dispersion technique, with key ingredients including HPMC (a polymer), PEG (a plasticizer), ethanol, and a permeation enhancer. The overarching goal was to assess the impact of polymer type, permeation enhancer, and sonication time on patch formulation and performance. To achieve our aim, we conducted several tests, including folding endurance, drug content, thickness, entrapment efficiency, in vitro moisture uptake, permeation analysis, and in vitro experiments. These specific objectives allowed us to evaluate the quality and effectiveness of the transdermal patches comprehensively. In our methodology, HPMC was employed as the polymer, and PEG served as the plasticizer. The Box-Behnken design facilitated kinetic assessments to study drug release from the patches. We systematically varied the HPMC, PEG, and ethanol concentrations and the sonication time to optimize patch formulation. The outcomes of our study indicated that all formulated patches met the specified criteria for quality and performance. Folding endurance was found to follow the formula +178.00 + 5.37A + 13.25B + 1.13C - 1.75AB + 0.0000AC + 0.2500BC + 4.25A² + 8.50B² + 2.75C², while permeation at 24 hours exhibited the equation +73.00 + 2.12A + 6.37B + 0.7500C - 0.5000AB - 0.2500AC - 0.2500BC + 1.00A² + 0.0000B² + 1.25C². These findings underscore the successful development of transdermal patches containing CPM and shed light on the critical factors influencing patch formulation. In summary, this investigation accomplished the development of transdermal patches incorporating CPM and elucidated the influence of polymer type, permeation enhancer, and sonication time on the formulation process. These findings contribute to advancing transdermal drug delivery systems and offer potential benefits for patients receiving anti-allergic medication.

References

Yang D, Chen M, Sun Y, Jin Y, Lu C, Pan X, et al. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021;121:119-33. doi: 10.1016/j.actbio.2020.12.004, PMID 33285323.

Yang G, Chen G, Gu Z. Transdermal drug delivery for hair regrowth. Mol Pharm. 2021;18(2):483-90. doi: 10.1021/acs.molpharmaceut.0c00041, PMID 32432880.

Vora LK, Moffatt K, Tekko IA, Paredes AJ, Volpe-Zanutto F, Mishra D, et al. Microneedle array systems for long-acting drug delivery. Eur J Pharm Biopharm. 2021;159:44-76. doi: 10.1016/j.ejpb.2020.12.006, PMID 33359666.

Roy D, Ahad HA, Chinthaginjala H, Kumar GA, Reddy GG, Teja AST. A possible alternative to Opiorphin and its stable analogs for treating fibromyalgia pain: A clinical hypothesis. North Clin Istanb. 2023;10(1):122-6. doi: 10.14744/nci.2022.92603, PMID 36910437.

Abdul Ahad H, Chinthaginjala H, Bhupalam P, Dasari R, Rao S, Tarun K. Designing dexamethasone sodium phosphate ocular films for madras eye: in vitro and in vivo evaluation; 2021. Available from: https://doi.org/2021Mar;34(2):607-613.

Annepogu H, Ahad HA, Nayakanti D. Determining the best poloxamer carrier for thiocolchicoside solid dispersions. Turk J Pharm Sci. 2020;17(4):372-80. doi: 10.4274/tjps.galenos.2019.78800, PMID 32939132.

Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, et al. Focus on over-the-counter drugs’ misuse: a systematic Review on antihistamines, cough medicines, and decongestants. Front Psychiatry. 2021;12:657397. doi: 10.3389/fpsyt.2021.657397, PMID 34025478.

Halmo LS, Wang GS, Reynolds KM, Delva-Clark H, Rapp-Olsson M, Banner W, et al. Pediatric fatalities associated with over-the-counter cough and cold medications. Pediatrics. 2021;148(5). doi: 10.1542/peds.2020-049536, PMID 34607934.

Ahad HA, Chinthaginjala H, Bhupalam P, Dasari RR, Rao BS, Tarun K. Designing of dexamethasone sodium phosphate ocular films for madras eye: in vitro and in vivo evaluation. Pak J Pharm Sci. 2021;34(2):607-13. PMID 34275836.

Monton C, Sampaopan Y, Pichayakorn W, Panrat K, Suksaeree J. Herbal transdermal patches made from optimized polyvinyl alcohol blended film: herbal extraction process, film properties, and in vitro study. J Drug Deliv Sci Technol. 2022;69:103170. doi: 10.1016/j.jddst.2022.103170.

Salama A, El-Hashemy HA, Darwish AB. Formulation and optimization of lornoxicam-loaded bilosomes using 23 full factorial designs for the management of osteoarthritis in rats: modulation of MAPK/Erk1 signaling pathway. J Drug Deliv Sci Technol. 2022;69:103175. doi: 10.1016/j.jddst.2022.103175.

Zafar A, Awad Alsaidan O, Alruwaili NK, Sarim Imam S, Yasir M, Saad Alharbi K et al. Formulation of intranasal surface engineered nanostructured lipid carriers of Rotigotine: full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Int J Pharm. 2022;627:122232. doi: 10.1016/j.ijpharm.2022.122232, PMID 36155794.

Kandil SM, Soliman II, Diab HM, Bedair NI, Mahrous MH, Abdou EM. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization, and clinical assessment in melasma patients. Drug Deliv. 2022;29(1):534-47. doi: 10.1080/10717544.2022.2036872, PMID 35156490.

Mishra SK, Kumar R, Patil PR, Gupta R, Mahor A, Bhardwaj P. Preparation and characterization of transdermal therapeutic system containing simvastatin: A statistical study. Indian J Pharm Educ Res. 2022;56(1):112-20. doi: 10.5530/ijper.56.1.14.

Viswanadhan Vasantha P, Sherafudeen SP, Rahamathulla M, Mathew ST, Murali S, Alshehri S, et al. Combination of cellulose derivatives and chitosan-based polymers to investigate the effect of permeation enhancers added to in situ nasal gels for the controlled release of loratadine and chlorpheniramine. Polymers. 2023;15(5):1206. doi: 10.3390/polym15051206, PMID 36904447.

Witika BA, Bassey KE, Demana PH, Siwe-Noundou X, Poka MS. Current advances in specialized liposomal drug delivery: manufacture, characterization and drug delivery applications. Int J Mol Sci. 2022 Aug 26;23(17):9668. doi: 10.3390/ijms23179668, PMID 36077066.

Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010 Jul;1(1):109-31. doi: 10.4155/tde.10.16, PMID 21132122.

Alissa I, Nair AB, Aldhubiab B, Shah H, Shah J, Mewada V et al. Design, development, and evaluation of treprostinil embedded adhesive transdermal patch. Pharmaceutics. 2023 Apr 12;15(4):1226. doi: 10.3390/pharmaceutics15041226, PMID 37111710.

Natori N, Shibano Y, Hiroki A, Taguchi M, Miyajima A, Yoshizawa K et al. Preparation and evaluation of hydrogel film containing tramadol for reduction of peripheral neuropathic pain. J Pharm Sci. 2023 Jan;112(1):132-7. doi: 10.1016/j.xphs.2022.05.013, PMID 35605686.

Tyeb S, Verma V, Kumar N. Polysaccharide based transdermal patches for chronic wound healing: recent advances and clinical perspective. Carbohydr Polym. 2023 Sep 15;316:121038. doi: 10.1016/j.carbpol.2023.121038, PMID 37321732.

Zhang X, Liu W, Wang W, Pi M, Huang B, Wu F. Evaluation of gum arabic double-layer microneedle patch containing sumatriptan for loading and transdermal delivery. Curr Drug Deliv. 2024;21(1):104-14. doi: 10.2174/1567201820666230309140636, PMID 36892114.

Birkodi S, Patil AS, Masareddy R, Rajpurohit M. Fabrication, optimization, and evaluation of transdermal patch: as an alternative and effective transdermal delivery system for nebivolol HCl. Pharm Nanotechnol. 2023 Jun 1. doi: 10.2174/2211738511666230601103658, PMID 37259931.

Pawar VK, Singh Y, Meher JG, Gupta S, Chourasia MK. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014 Jun 10;183:51-66. doi: 10.1016/j.jconrel.2014.03.030, PMID 24667572.

Jain J S, Patel N, Madan P, Lin S. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharmaceutical development and technology. 2015 May 19;20(4):473-89. https://doi.org/10.3109/10837450.2014.882939.

Sintov AC, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm. 2006 Mar 27;311(1-2):55-62. doi: 10.1016/j.ijpharm.2005.12.019, PMID 16431047.

Bui VD, Son S, Xavier W, Nguyen VQ, Jung JM, Lee J et al. Dissolving microneedles for long-term storage and transdermal delivery of extracellular vesicles. Biomaterials. 2022 Aug 1;287:121644. doi: 10.1016/j.biomaterials.2022.121644, PMID 35772350.

Kolimi P, Narala S, Youssef AAA, Nyavanandi D, Dudhipala N. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery. Nanotheranostics. 2023;7(1):70-89. doi: 10.7150/ntno.77395, PMID 36593800.

Zaid Alkilani A, Musleh B, Hamed R, Swellmeen L, Basheer HA. Preparation and characterization of patch loaded with clarithromycin nanovesicles for transdermal drug delivery. J Funct Biomater. 2023 Jan 19;14(2):57. doi: 10.3390/jfb14020057, PMID 36826856.

Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: A novel Nano carrier as a tool for topical drug delivery. Pharmaceutics. 2023 Jan 3;15(1):164. doi: 10.3390/pharmaceutics15010164, PMID 36678794.

Jafari A, Daneshamouz S, Ghasemiyeh P, Mohammadi-Samani S. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization. J Liposome Res. 2023 Jan 2;33(1):34-52. doi: 10.1080/08982104.2022.2085742, PMID 35695714.

Published

2023-11-01

How to Cite

Abdul Ahad, H. ., Dheeraj, S., & Chinthaginjala, H. . (2023). Enhancing Anti-Allergic Transdermal Patches Through Box-Behnken Design Approach with Chlorpheniramine Maleate: Pharmaceutical sciences- Pharmaceutics. International Journal of Life Science and Pharma Research, 13(6), P366-P377. https://doi.org/10.22376/ijlpr.2023.13.6.P366-P377

Issue

Section

Research Articles